×
MSP Recovery EBITDA 2020-2025 | MSPR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
MSP Recovery ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
MSP Recovery EBITDA 2020-2025 | MSPR
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
MSP Recovery ebitda from 2020 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Veeva Systems (VEEV)
$46.1B
Doximity (DOCS)
$12.5B
Hims & Hers Health (HIMS)
$11.6B
Tempus AI (TEM)
$10.5B
IRhythm Technologies (IRTC)
$5.1B
Hinge Health (HNGE)
$4.4B
Privia Health (PRVA)
$2.5B
Inspire Medical Systems (INSP)
$2.3B
Enovis (ENOV)
$1.6B
Phreesia (PHR)
$1.6B
10x Genomics (TXG)
$1.5B
Omnicell (OMCL)
$1.4B
Schrodinger (SDGR)
$1.4B
Azenta (AZTA)
$1.3B
Clover Health Investments (CLOV)
$1.1B
Evolent Health (EVH)
$1.1B
Claritev (CTEV)
$934M
Fulgent Genetics (FLGT)
$623M
Veradigm (MDRX)
$514M
Standard BioTools (LAB)
$496M
Talkspace (TALK)
$418M
Zepp Health (ZEPP)
$360M
Carlsmed (CARL)
$337M
Butterfly Network (BFLY)
$335M
TruBridge (TBRG)
$284M
Nyxoah SA (NYXH)
$253M
Outset Medical (OM)
$227M
SOPHiA GENETICS SA (SOPH)
$215M
Health Catalyst (HCAT)
$197M
KORU Medical Systems (KRMD)
$183M